Target intelligence / Profile preview

Interstitial cell of Cajal (ICC)

Target
ICC
Molecular classification
Other (specialized mesenchymal cell), Pacemaker cell (cell, not molecule or receptor), Kit-positive cell (expresses KIT protein)
01

Overview

Interstitial cells of Cajal (ICC) are specialized mesenchymal cells within the muscular layers of the gastrointestinal tract. These cells function as pacemakers, generating electrical slow waves that synchronize and regulate the rhythmic contractions of smooth muscle necessary for proper motility. ICC modulate signals from the enteric nervous system and are morphologically characterized by their small cell bodies and multiple branching processes that contact both smooth muscle and neural cells. ICCs can be identified by their expression of the c-KIT protein and form syncytial networks via gap junctions. Dysfunction or loss of ICC is associated with a variety of gastrointestinal motility disorders, and oncogenic transformation gives rise to gastrointestinal stromal tumours (GISTs). Because ICC are cells (not molecules or receptors), they are not considered canonical therapeutic targets as commonly defined, though their molecular features (such as KIT) have clinical relevance in GIST.

Other names
ICCCajal cellCajal'sche zellenGI pacemaker cell
02

Mechanism of action

In the case of GIST: inhibition of KIT tyrosine kinase activity by small molecule inhibitors such as imatinib

03

Biological functions

Generation of electrical slow waves (pacemaker activity) for GI motilityMediation and modulation of enteric nervous signals to smooth muscleMechanical sensation in the GI tract
04

Disease associations

Gastrointestinal stromal tumour (GIST) originChronic intestinal pseudo-obstructionDiabetic gastropathy and other motility disorders
05

Safety considerations

Loss or functional impairment can lead to GI motility disordersHyperplasia or mutation (KIT mutation) may result in GIST formationDrug targeting KIT can have off-target effects in other cell types
06

Interacting drugs

07

Biomarkers

c-KIT (CD117) immunoreactivityAnoctamin-1 (ANO1/TMEM16A)

Beyond the preview

Go deeper on Interstitial cell of Cajal (ICC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interstitial cell of Cajal (ICC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call